75% ALCOHOL DISNFECTANT is a Topical Liquid in the Human Otc Drug category. It is labeled and distributed by Zhejiang Jinghui Cosmetics Co.,ltd. The primary component is Alcohol.
| Product ID | 73905-002_a1e6a070-3268-5d5b-e053-2a95a90a64a9 |
| NDC | 73905-002 |
| Product Type | Human Otc Drug |
| Proprietary Name | 75% ALCOHOL DISNFECTANT |
| Generic Name | 75% Alcohol Disnfectant |
| Dosage Form | Liquid |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part333A |
| Labeler Name | Zhejiang Jinghui Cosmetics Co.,LTD |
| Substance Name | ALCOHOL |
| Active Ingredient Strength | 75 mL/100mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-10 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-10 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing End Date | 2020-05-19 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-30 |
| Marketing Category | OTC monograph not final |
| Application Number | part333A |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-03-31 |
| Ingredient | Strength |
|---|---|
| ALCOHOL | 75 mL/100mL |
| SPL SET ID: | a20adc05-fd91-12bf-e053-2995a90a841c |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 73905-002 | 75% ALCOHOL DISNFECTANT | 75% ALCOHOL DISNFECTANT |
| 73905-011 | 75% ALCOHOL DISNFECTANT | 75% ALCOHOL DISNFECTANT |
| 73905-023 | 75% ALCOHOL DISNFECTANT | 75% ALCOHOL DISNFECTANT |
| 73905-030 | 75% ALCOHOL DISNFECTANT | 75% ALCOHOL DISNFECTANT |